Hong Kong Commercial Services Stock News

SEHK:2367
SEHK:2367Personal Products

Did Giant Biogene’s New Buyback Plan Just Shift Giant Biogene Holding's (SEHK:2367) Investment Narrative?

Earlier in December, Giant Biogene Holding announced a share repurchase plan, following recent analyst coverage from Citic Securities, Citi and UBS. The buyback move is being read as a signal of management confidence and a direct attempt to enhance shareholder value. With the share repurchase plan now in place, we’ll explore how this capital allocation decision shapes Giant Biogene’s broader investment narrative. AI is about to change healthcare. These 30 stocks are working on everything...
SEHK:1530
SEHK:1530Biotechs

Why 3SBio (SEHK:1530) Is Down 10.1% After HK$3.12 Billion Follow-on Equity Offering And Portfolio Shift

3SBio Inc. recently completed a follow-on equity offering of HK$3.12 billion via a subsequent direct listing, issuing 105,169,500 ordinary shares at HK$29.62 each. The fundraise, paired with the planned divestment of its cash-generating hair-loss unit, underlines 3SBio’s push to become a focused innovator in late-stage biopharmaceuticals. With the shares posting a 10.14% seven-day decline, we’ll explore how this capital raise and portfolio refocus reshape 3SBio’s investment narrative. Find...
SEHK:3
SEHK:3Gas Utilities

Hong Kong and China Gas (SEHK:3) Valuation After Major AWS Cloud and AI Modernization Drive

Hong Kong and China Gas (SEHK:3) just pushed a big chunk of its core infrastructure onto Amazon Web Services with partner eCloudvalley, aiming for up to 40% lower IT costs and 99.99% uptime on mission critical systems. See our latest analysis for Hong Kong and China Gas. The HK$7.18 share price has held up reasonably well this year, with a 17.5% year to date share price return and a 24.8% one year total shareholder return suggesting improving sentiment as investors warm to its gradual...